Epstein Secrets

at current levels. The fundamental bull case for Health rests on the strong pipeline of new products for

ation. Fac pa | ities. None of MLPF&S, any of i Research policy prohibits rese containing such rating, rec

ervices 1,720 Tax credit for orphan drug research Health 100 Exclusion & deferral of policyholder income e

other busi his re ities. None of MLPF&S, any of i Research policy prohibits rese containing such rating, rec

ncrease penetration of higher margin offerings 48 Health: Not Tremendously Prescriptive 51 Vision 2030 a s

am, I/B/E/S, Bloomberg, BofA Merrill Lynch Global Research OS Merrill Lynch GEMs Paper #26|30 June 2016 43

3% -] 2% 74 3.1% = 2% 3.2 -0.4% 0 54% 0.9% SXDP (Health) 3.1% -0.6% 2% 86% 0.9% -/ 2% 115 24% -14 2% 4]

ompensation received from, such issuers in BofA research reports. To the extent this report discusses any